CD163 and cancer: Kaplan-Meier analysis of overall survival in lung cancer patients based on M-CSF and CD163 expression showed that high expression of both M-CSF and CD163 in cancer tissues correlates with poor survival compared to other groups (Fig. 5b), consistent with previous reports28.